1 / 10

Drug Stores: Walmart

Drug Stores: Walmart. Eric Biro. Industry Trends. 30 million Americans will gain health coverage by 2018 By 2020, 20% of consumers will directly choose their own health plan By 2020, there is an estimated 45,000 physician shortage

nysa
Download Presentation

Drug Stores: Walmart

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Drug Stores: Walmart Eric Biro

  2. Industry Trends • 30 million Americans will gain health coverage by 2018 • By 2020, 20% of consumers will directly choose their own health plan • By 2020, there is an estimated 45,000 physician shortage • Many drug stores are diversifying their services as margins compress • Offering flu shots, quick clinics in-store • Time of transformation in the healthcare industry, trickles down into drug store industry Source: http://www.drugstorenews.com/article/cvs-caremarks-ability-and-agility-key-focus-2014-analyst-day

  3. The Industry - drug stores • Well-known, established specialty chains • Walgreens, CVS, Rite Aid • Pharmacy a main draw • Sell health & beauty products, over-the-counter drugs, photo-finishing services • Operations: merchandising (which items to stock), advertising, inventory management, billing, personnel management • High-inventory, moderate receivables • Challenge: margins decreasing rapidly • In-store pharmacies • Retailers that have added pharmacies onto their product offerings • Growing source of competition for traditional pharmacies • Walmart, Kroger Source: http://corp.bankofamerica.com/publicpdf/products/industries/sampleprofile.pdf

  4. The Industry - Pharmacy Benefit Managers (PBMs) • Pharmacy purchases drugs from supplier • Insured patient buys drugs from pharmacy • Must purchase at a pharmacy that has contract with insurer’s PBM • Patient pays part of total upon receipt • Pharmacy bills patient’s insurance for remainder of payment • PBM negotiates lower reimbursement for insurer to pharmacy • Possible through size of PBM and bargaining power that comes with size • Insurer pays less to pharmacy because of PBM negotiation • PBM takes part of this profit for its services • Pharmacies have contracts with several PBMs • Walgreens and CVS Caremark

  5. The Industry - Pharmacy Benefit Managers (PBMs) • Traditional PBMs • 60 major in the U.S. • Largest Express Scripts (just purchased one of the other top 3) • Intense competition and huge barriers to entry • Combination PBM/Drug Stores • CVS Caremark

  6. Comparable Firms • Walgreens Co. • 2013: $72.2 B in sales, $45.5 B in prescription sales • CVS Caremark • 2012: $123.0 B in revenue (including PBM revenue) • Walmart • 2013: $37.0 B in Health & Wellness net sales • Express Scripts • 2012: $93.9 B in revenue

  7. Walmart background • Saving people money to live better through everyday low prices • Mass merchandiser of consumer products • 3 business segments (U.S., International, Sam’s Club) • Supercenters, discount stores (4,005 stores) • $466.1 billion in net sales in fiscal 2013 (59%/29%/12%) • 11% of U.S. /5% of Sam’s net sales attributable to health & wellness (pharmacy, optical services, over-the-counter drugs) • Broad distribution networks (81%/64% of purchases through Walmart owned facilities) • 2.2 million employees serving 200 million customers each week Source: Walmart 2013 10-K

  8. Walmart pharmacy • Expanded into pharmacy in 1977 • $4 generics program started in 2006 • Average was $29, used mass distribution tactics to sell at a profit still • Reduced America’s drug bill by $1 billion in under 2 years • Gingerly stepping into PBM role • Offering businesses ability to buy low-price drugs if it buys directly from Walmart’s in-store pharmacies (Caterpillar, 400 others) • Has the potential to fundamentally change the way PBMs operate/price • Added walk-in clinics in over 400 stores in 2010 Sources: http://www.npr.org/templates/story/story.php?storyId=6119292 http://www.managedcaremag.com/archives/0804/0804.walmart.html http://online.wsj.com/news/articles/SB124138786561981235

  9. SWOT Analysis – Internal Factors • Strengths • Supply chain • Bargaining power • Brand name recognition, association with low prices • Strong culture for health (save money, live better) • Weaknesses • Legal issues • Negative brand name association (workers, importing) • Tendency to aim larger than it should

  10. SWOT Analysis –External Factors • Opportunities • PBM model facing margin crunch (generics) • Renewed focus on American healthcare from ACA • Shady practice of PBMs, can build on better parts of their model • Threats • Overextension into an unfamiliar market • What does failure lead to?

More Related